Zenas BioPharma Inc. (ZBIO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zenas BioPharma Inc.

    NASDAQ: ZBIO · Real-Time Price · USD
    23.01
    1.25 (5.74%)
    At close: Oct 06, 2025, 2:49 PM

    Zenas BioPharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Cash & Equivalents
    		 319.74M 56.86M 67.21M
    Short-Term Investments
    		 31.02M n/a n/a
    Long-Term Investments
    		 n/a 86K 86K
    Other Long-Term Assets
    		 12.86M 7.28M 4.25M
    Receivables
    		 n/a n/a n/a
    Inventory
    		 n/a n/a n/a
    Other Current Assets
    		 5.16M 2.95M 1.24M
    Total Current Assets
    		 355.92M 59.8M 68.44M
    Property-Plant & Equipment
    		 1.19M 1.01M 1.8M
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 14.04M 8.38M 6.13M
    Total Assets
    		 369.97M 68.18M 74.58M
    Account Payables
    		 17.14M 5.4M 5.82M
    Deferred Revenue
    		 n/a n/a n/a
    Short-Term Debt
    		 785K 556K 715K
    Other Current Liabilities
    		 -785K 4.57M 3.62M
    Total Current Liabilities
    		 57.29M 23.26M 25.97M
    Long-Term Debt
    		 n/a 20.3M n/a
    Other Long-Term Liabilities
    		 n/a 250.09M 240.09M
    Total Long-Term Liabilities
    		 218K 270.64M 240.9M
    Total Liabilities
    		 57.51M 293.9M 266.87M
    Total Debt
    		 1M 21.11M 1.53M
    Book Value
    		 312.46M -225.72M -192.29M
    Book Value Per Share
    		 7.48 -5.89 -5.02
    Common Stock
    		 4K 1K 1K
    Retained Earnings
    		 -387.39M -230.4M -193.28M
    Comprehensive Income
    		 194K 37K -41K
    Shareholders Equity
    		 312.46M -225.72M -192.29M
    Total Investments
    		 31.02M 86K 86K

    Add to Watchlist